ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Dacomitinib Tablet shortage

To Be Discontinued  3 presentations · 1 manufacturers · first FDA posting 2026-06-08 · last update 2026-06-08

Manufacturers: Pfizer Inc.

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Vizimpro, Tablet, 15 mg (NDC 0069-0197-30)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 06/08/2026
Updated 06/08/2026
Discontinued 06/08/2026
Vizimpro, Tablet, 30 mg (NDC 0069-1198-30)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 06/08/2026
Updated 06/08/2026
Discontinued 06/08/2026
Vizimpro, Tablet, 45 mg (NDC 0069-2299-30)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 06/08/2026
Updated 06/08/2026
Discontinued 06/08/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)